Search for: "United States v. Boston Scientific Corp." Results 41 - 60 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Aug 2013, 11:09 am
Boston Scientific Corp., 695 F.3d 1266 (Fed. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
” Validity – Indefiniteness: American Technical Ceramics Corp. v. [read post]
20 Mar 2009, 9:00 am
(Afro-IP)   United Kingdom EWHC: Independent consultant held jointly liable for infringement: MMI Research Ltd v Cellxion Ltd (PatLit) Can THE JOURNAL ever be distinctive for a journal? [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
22 May 2014, 5:00 am
  Generally, government employees are immune from discovery in private litigation under rules first set out in United States ex rel. [read post]
16 Sep 2011, 8:17 am by Bexis
Boston Scientific Neuromodulation Corp., 2011 U.S. [read post]
12 Feb 2014, 9:24 am
Boston Scientific Corp., 631 F.3d 762 (5th Cir. 2011), and Bausch v. [read post]
10 Mar 2011, 10:50 am by Bexis
  Answer:  Because of the effect on “further appellate review” – which means the United States Supreme Court. [read post]
27 Jul 2014, 9:03 am by Schachtman
Over 20 years ago, in 1993, the United States Supreme Court handed down its Daubert decision. [read post]